Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Vera J . Suman, Ph.D.

Back to Research Profile

  1. Halyard MY, Pisansky TM, Dueck AC, Suman VJ, Pierce LJ, Solin LJ, Marks LB, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil S, Perez EA. Reply to N. Magne et al. J Clin Oncol 2009 Nov 02. [Epub ahead of print]
    View PubMed
  2. Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S, Fritz P, Simon W, Suman VJ, Ames MM, Safgren SL, Kuffel MJ, Ulmer HU, Bolander J, Strick R, Beckmann MW, Koelbl H, Weinshilboum RM, Ingle JN, Eichelbaum M, Schwab M, Brauch H. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA 2009 Oct 7; 302(13):1429-36.
    View PubMed
  3. Litzow MR, Peethambaram PP, Safgren SL, Keeney GL, Ansell SM, Dispenzieri A, Elliott MA, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Lingle WL, Hartmann LC, Frost MH, Barrette BA, Long HJ, Suman VJ, Reid JM, Ames MM, Kaufmann Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma. Bone Marrow Transplant 2009 Aug 03. [Epub ahead of print]
    View PubMed
  4. Grant CS, Ingle JN, Suman VJ, Dumesic DA, Wickerham DL, Gelber RD, Flynn PJ, Weir LM, Intra M, Jones WO, Perez EA, Hartmann LC. Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study. J Clin Oncol 2009 Aug 1; 27(22):3620-6. Epub 2009 Jun 01.
    View PubMed
  5. Halyard MY, Pisansky TM, Dueck AC, Suman V, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil SR, Perez EA. Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol 2009 Jun 1; 27(16):2638-44. Epub 2009 Apr 06.
    View PubMed
  6. Perez DG, Suman VJ, Fitch TR, Amatruda T 3rd, Morton RF, Jilani SZ, Constantinou CL, Egner JR, Kottschade LA, Markovic SN. Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A. Cancer 2009 Jan 1; 115(1):119-27.
    View PubMed
  7. Markovic SN, Suman VJ, Nevala WK, Geeraerts L, Creagan ET, Erickson LA, Rowland KM Jr, Morton RF, Horvath WL, Pittelkow MR. A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study. Am J Clin Oncol 2008 Dec; 31(6):573-9.
    View PubMed
  8. Goetz MP, Suman VJ, Couch FJ, Ames MM, Rae JM, Erlander MG, Ma XJ, Sgroi DC, Reynolds CA, Lingle WL, Weinshilboum RM, Flockhart DA, Desta Z, Perez EA, Ingle JN. Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. Clin Cancer Res 2008 Sep 15; 14(18):5864-8.
    View PubMed
  9. Suman VJ, Dueck A, Sargent DJ. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis. Cancer Invest 2008 Jun; 26(5):439-44.
    View PubMed
  10. Gilbert JA, Goetz MP, Reynolds CA, Ingle JN, Giordano KF, Suman VJ, Blair HE, Jenkins RB, Lingle WL, Reinholz MM, Adjei AA, Ames MM. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy. Mol Cancer Ther 2008 Apr; 7(4):944-51.
    View PubMed
  11. Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol 2008 Mar 10; 26(8):1231-8. Epub 2008 Feb 04.
    View PubMed
  12. Korn EL, Liu PY, Lee SJ, Chapman JA, Niedzwiecki D, Suman VJ, Moon J, Sondak VK, Atkins MB, Eisenhauer EA, Parulekar W, Markovic SN, Saxman S, Kirkwood JM. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol 2008 Feb 1; 26(4):527-34.
    View PubMed
  13. Alberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J. Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial. Int J Gastrointest Cancer 2008 Jan 03. [Epub ahead of print]
    View PubMed
  14. Melanoma Study Group of the Mayo Clinic Cancer Center, Celis E. Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction. Cancer 2007 Jul 1; 110(1):203-14.
    View PubMed
  15. Melanoma Study Group of the Mayo Clinic Cancer Center, Celis E. Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction. Cancer 2007 Jul 1; 110(1):203-14.
    View PubMed
  16. Markovic SN, Suman VJ, Rao RA, Ingle JN, Kaur JS, Erickson LA, Pitot HC, Croghan GA, McWilliams RR, Merchan J, Kottschade LA, Nevala WK, Uhl CB, Allred J, Creagan ET. A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma. Am J Clin Oncol 2007 Jun; 30(3):303-9.
    View PubMed
  17. Vachon CM, Ingle JN, Suman VJ, Scott CG, Gottardt H, Olson JE, Goss PE. Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. Breast 2007 Apr; 16(2):204-10.
    View PubMed
  18. Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Weinshilboum RM, Fritcher EG, Nibbe AM, Desta Z, Nguyen A, Flockhart DA, Perez EA, Ingle JN. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 2007 Jan; 101(1):113-21. Epub 2006 Nov 18.
    View PubMed
  19. Markovic SN, Suman VJ, Ingle JN, Kaur JS, Pitot HC, Loprinzi CL, Rao RD, Creagan ET, Pittelkow MR, Allred JB, Nevala WK, Celis E. Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization. Am J Clin Oncol 2006 Aug; 29(4):352-60.
    View PubMed
  20. Perez EA, Suman VJ, Davidson NE, Martino S, Kaufman PA, Lingle WL, Flynn PJ, Ingle JN, Visscher D, Jenkins RB. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. J Clin Oncol 2006 Jul 1; 24(19):3032-8.
    View PubMed
  21. Ingle JN, Suman VJ, Mailliard JA, Kugler JW, Krook JE, Michalak JC, Pisansky TM, Wold LE, Donohue JH, Goetz MP, Perez EA. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52. Breast Cancer Res Treat 2006 Jul; 98(2):217-22. Epub 2006 Mar 15.
    View PubMed
  22. Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ. A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res 2006 Apr 1; 12(7 Pt 1):2080-7.
    View PubMed
  23. Baweja M, Suman VJ, Fitch TR, Mailliard JA, Bernath A, Rowland KM, Alberts SR, Kaur JS, Perez EA. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients >= 65 years of age: an NCCTG study. Ann Oncol 2006 Apr; 17(4):623-9.
    View PubMed
  24. Baweja M, Suman VJ, Fitch TR, Mailliard JA, Bernath A, Rowland KM, Alberts SR, Kaur JS, Perez EA, Ncctg. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study. Ann Oncol 2006 Apr; 17(4):623-9. Epub 2006 Mar 06.
    View PubMed
  25. Ingle JN, Suman VJ, Rowland KM, Mirchandani D, Bernath AM, Camoriano JK, Fishkin PAS, Nikcevich DA, Perez EA. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group trial N0032. J Clin Oncol 2006 Mar 1; 24(7):1052-6.
    View PubMed
  26. Ingle JN, Suman VJ, Rowland KM, Mirchandani D, Bernath AM, Camoriano JK, Fishkin PA, Nikcevich DA, Perez EA, North Central Cancer Treatment Group Trial N0032. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. J Clin Oncol 2006 Mar 1; 24(7):1052-6.
    View PubMed
  27. Long HJ 3rd, Nelimark RA, Podratz KC, Suman V, Keeney GL, Nikcevich DA, Kugler JW, Rowland KM Jr, Kardinal CG, Wos EJ. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium. Gynecol Oncol 2006 Mar; 100(3):501-5. Epub 2005 Sep 26.
    View PubMed
  28. Long HJ, Nelimark RA, Podratz KC, Suman V, Keeney GL, Nikeevich DA, Kugler JW, Rowland KM, Kardinal CG, Wos EJ. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium. Gynecol Oncol 2006 Mar; 100(3):501-5.
    View PubMed
  29. Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol 2005 Dec 20; 23(36):9312-8.
  30. Perez EA, Suman VJ, Rowland KM, Ingle JN, Salim M, Loprinzi CL, Flynn PJ, Mailliard JA, Kardinal CG, Krook JE, Thrower AR, Visscher DW, Jenkins RB. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer 2005 Dec; 6(5):425-32.
    View PubMed
  31. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein P Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New Engl J Med 2005 Oct 20; 353(16):1673-84.
    View PubMed
  32. Ghosh K, Melton LJ, Suman VJ, Grant CS, Sterioff S, Brandt KR, Branch C, Sellers TA, Hartmann LC. Breast biopsy utilization - A population-based study. Archives of Internal Medicine 2005 Jul 25; 165(14):1593-8.
    View PubMed
  33. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW. Benign breast disease and the risk of breast cancer. N Engl J Med 2005 Jul 21; 353(3):229-37.
    View PubMed
  34. Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res 2005 May 15; 11(10):3722-32.
    View PubMed
  35. Ingle JN, Suman VJ. Aromatase inhibitors for therapy of advanced breast cancer. J Steroid Biochem Molec Biol 2005 May; 95(1-5):113-9.
    View PubMed
  36. Lafky JM, Baron LT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ. Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole. Cancer Res 2005 Apr 15; 65(8):3059-62.
    View PubMed
  37. Dowdy SC, Metzinger DS, Gebhart JB, Srivatsa P, Haddock MG, Suman VJ, Podratz KC. Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer. Gynecol Oncol 2005 Feb; 96(2):389-94.
    View PubMed
  38. Perez EA, Suman VJ, Fitch TR, Mailliard JA, Ingle JN, Cole JT, Veeder MH, Flynn PJ, Walsh DJ, Addo FK. A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932. Oncology 2005; 69(2):117-21.
    View PubMed
  39. Perez EA, Suman VJ, Davidson NE, Kaufman PA, Martino S, Dakhil SR, Ingle JN, Rodeheffer RJ, Gersh BJ, Jaffe AS. Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. J Clin Oncol 2004 Sep 15; 22(18):3700-4.
    View PubMed
  40. Miller DV, Leontovich AA, Lingle WL, Suman VJ, Mertens ML, Lillie J, Ingalls KA, Perez EA, Ingle JN, Couch FJ, Visscher DW. Utilizing Nottingham prognostic index in microarray gene expression profiling of breast carcinomas. Mod Pathol 2004 Jul; 17(7):756-64.
    View PubMed
  41. Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, Roche PC, Spelsberg TC. Differential gene expression of TGF inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Research & Treatment 2004 Jul; 86(1):75-88.
    View PubMed
  42. Dowdy SC, Constantinou CL, Hartmann LC, Keeney GL, Suman VJ, Hillman DW, Podratz KC. Long-term follow-up of women with ovarian cancer after positive second-look laparotomy. Gynecol Oncol 2003 Dec; 91(3):563-8.
    View PubMed
  43. Ingle JN, Suman VJ. Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings. Journal of Steroid Biochemistry & Molecular Biology 2003 Sep; 86(3-5):313-9.
    View PubMed
  44. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Research & Treatment 2003 Jul; 80(1):99-104.
    View PubMed
  45. Korndorfer SR, Lucas AR, Suman VJ, Crowson CS, Krahn LE, Melton LJ. Long-term survival of patients with anorexia nervosa: A population-based study in Rochester, Minn. Mayo Clin Proc 2003 Mar; 78(3):278-84.
    View PubMed
  46. Markovic S, Suman VJ, Dalton RJ, Woods JE, Fitzgibbons RJ Jr, Wold LE, Buckner JC, Kugler JW, Mailliard JA, Rowland KM, Krook JE, Brown DW, Tirona MT, Creagan ET. Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma. Am J Clin Oncol 2002 Dec; 25(6):552-6.
    View PubMed
  47. Pisansky TM, Blute ML, Hillman DW, Davis BJ, Haddock MG, Suman VJ, Wilson TM, Zincke H. The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinoma. Cancer 2002 Aug 1; 95(3):513-9.
    View PubMed
  48. Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK, Maihle N, Michalak JC, Kuross SA, Kugler JW, Lafky JM, Ingle JN. A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer. Ann Oncol 2002 Aug; 13(8):1225-35.
    View PubMed
  49. Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN, Perez EA. Determination of HER2 status for the Breast Intergroup Trial N9831: Preliminary results of concordance between community and central Laboratory testing and the correlation of overexpression and amplification. J Natl Cancer Inst 2002 Jun 5; 94(11):855-7.
    View PubMed
  50. Markovic SN, Suman VJ, Vukov AM, Fitch TR, Hillman DW, Adjei AA, Alberts SR, Kaur JS, Braich TA, Leitch JM, Creagan ET. Phase II trial of KW2189 in patients with advanced malignant melanoma. Am J Clin Oncol 2002 Jun; 25(3):308-12.
    View PubMed
  51. Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 2002 May; 8(5):1085-91.
    View PubMed
  52. Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Cancer 2002 Apr 15; 94(8):2224-31.
    View PubMed
  53. Maihle NJ, Lafky JM, Baron AT, Boardman CH, Greenwood TM, Christensen TA, Reiter JL, Cora EM, Lee H, Suman VJ, Fishman DA, Perez EA, Podratz KC. EGF receptor/ErbB isoforms as serum biomarkers in breast and ovarian cancer. Journal of Clinical Ligand Assay 2002 Spr; 25(1):57-60.
  54. Long HJ, Rayson S, Podratz KC, Abu-Ghazaleh S, Suman V, Buckner JC, Levitt R, Nair S, Hatfield AK, Kugler JW. Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with or without the addition of molgramostim in women with advanced/recurrent cervix cancer. American Journal of Clinical Oncology 2002; 25(6):547-551.
    View PubMed
  55. Baron AT, Lafkyk JM, Suman VJ, Hillman DW, Buenafe MC, Boardman CH, Podratz KC, Perez EA, Maihle NJ. A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women. Cancer Epidemiol Biomarkers Prev 2001 Nov; 10(11):1175-85.
    View PubMed
  56. Gostout BS, Hartmann LC, Suman VJ, Fay NE, Jefferies JA, Morton RF, Gaffey TA, Farr GH, Tschetter LK, Abu- Ghazaleh S, Gallenberg MM, Hatfield AK. A randomized trial of interferon-alpha in cervical dysplasia. Int J Gynaecol Obstet 2001 Aug; 74(2):207-210.
    View PubMed
  57. Schneekloth TD, Morse RM, Herrick LM, Suman VJ, Offord KP, Davis LJ Jr. Point prevalence of alcoholism in hospitalized patients: continuing challenges of detection, assessment, and diagnosis. Mayo Clin Proc 2001 May; 76(5):460-6.
    View PubMed
  58. Edmonson JH, Suman VJ, Dalton RJ, Bro WC, Gallenberg MM, Long HJ, Levitt R, Hatfield AK, Krook JE, Mailliard JA, Gerstner JB. Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study. Cancer Invest 2001; 19(6):597-602.
    View PubMed
  59. Hanson Frost M, Suman VJ, Rummans TA, Dose AM, Taylor M, Novotny P, Johnson R, Evans RE. Physical, psychological and social well-being of women with breast cancer: the influence of disease phase. Psychooncology 2000 May-Jun; 9(3):221-31.
    View PubMed
  60. Frost MH, Walsh Vockley C, Suman VJ, Greene MH, Zahasky K, Hartmann L. Perceived familial risk of cancer: health concerns and psychosocial adjustment. J Psychosoc Oncol 2000; 18(1):63-82.
    View PubMed
  61. Madson TJ, Youdas JW, Suman VJ. Reproducibility of lumbar spine range of motion measurements using the back range of motion device. J Orthop Sports Phys Ther 1999 Aug; 29(8):470-7.
    View PubMed
  62. Ingle JN, Suman VJ, Johnson PA, Krook JE, Mailliard JA, Wheeler RH, Loprinzi CL, Perez EA, Jordan VC, Dowsett M. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Clin Cancer Res 1999 Jul; 5(7):1642-9.
    View PubMed
  63. Maguire-Boston EK, Suman V, Jacobsen SJ, Moore SB, Habermann TM, Cerhan JR, Folsom AR. Blood transfusion and risk of non-Hodgkin's lymphoma. Am J Epidemiol 1999 Jun 15; 149(12):1113-8.
    View PubMed
  64. Ingle JN, Suman VJ, Jordan VC, Dowsett M. Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer. Endocr Relat Cancer 1999 Jun; 6(2):265-9.
    View PubMed
  65. Creagan ET, Suman VJ, Dalton RJ, Pitot HC, Long HJ, Veeder MH, Vukov AM, Rowland KM, Krook JE, Michalak JC. Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma. J Clin Oncol 1999 Jun; 17(6):1884-90.
    View PubMed
  66. Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 1999 Apr; 10(4):413-9.
    View PubMed
  67. Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer 1999 Mar 15; 85(6):1284-92.
    View PubMed
  68. Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Research & Treatment 1999 Mar; 54(2):117-22.
    View PubMed
  69. Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 1999 Feb; 8(2):129-37.
    View PubMed
  70. Madison TJ, Youdas JW, Suman VJ, Hanson TJ. Reproducibility measurements of lumbar spine range of motion: A comparison of two methods. JOurnal of Orthopedic and Sports Physical Therapy 1999; 29(8):470-477.
    View PubMed
  71. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, Donohue JH. Molecular markers in male breast carcinoma. Cancer 1998 Nov 1; 83(9):1947-55.
    View PubMed
  72. Baron AT, Lafky JM, Connolly DC, Peoples J, O'Kane DJ, Suman VJ, Boardman CH, Podratz KC, Maihle NJ. A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera. J Immunol Methods 1998 Oct 1; 219(1-2):23-43.
    View PubMed
  73. Creagan ET, Veeder MH, Suman VJ, Burch PA, Maples WJ, Schaefer PL, Pfeifle DM, Dalton RJ, Hatfield AK, Poon MA. A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma. Am J Clin Oncol 1998 Oct; 21(5):475-8.
    View PubMed
  74. Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 1998 Oct; 73(10):936-42.
    View PubMed
  75. Rummans TA, Frost M, Suman VJ, Taylor M, Novotny P, Gendron T, Johnson R, Hartmann L, Dose AM, Evans RW. Quality of life and pain in patients with recurrent breast and gynecologic cancer. Psychosomatics 1998 Sep-Oct; 39(5):437-45.
    View PubMed
  76. Stafford SL, Perry A, Leavitt JA, Garrity JA, Suman VJ, Scheithauer BW, Lohse CM, Meyer FB. Anterior visual pathway meningiomas primarily resected between 1978 and 1988: the Mayo Clinic Rochester experience. J Neuroophthalmol 1998 Sep; 18(3):206-10.
    View PubMed
  77. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 1998 Jun 1; 82(11):2262-9.
    View PubMed
  78. Orvidas LJ, Olsen KD, Lewis JE, Suman VJ. Verrucous carcinoma of the larynx: a review of 53 patients. Head & Neck 1998 May; 20(3):197-203.
    View PubMed
  79. Yawn BP, Suman VJ, Jacobsen SJ. Maternal recall of distant pregnancy events. J Clin Epidemiol 1998 May; 51(5):399-405.
    View PubMed
  80. Creagan ET, Hestorff RD, Suman VJ, Mailliard JA, Nair S, Krook JE, Kugler JW, Marschke RF Jr, Michalak JC, Tschetter LK. Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study. Am J Clin Oncol 1998 Apr; 21(2):139-41.
    View PubMed
  81. Schiff D, Suman VJ, Yang P, Rocca WA, O'Neill BP. Risk factors for primary central nervous system lymphoma: a case-control study. Cancer 1998 Mar 1; 82(5):975-82.
    View PubMed
  82. Moellentine C, Rummans T, Ahlskog JE, Harmsen WS, Suman VJ, O'Connor MK, Black JL, Pileggi T. Effectiveness of ECT in patients with parkinsonism. Journal of Neuropsychiatry & Clinical Neurosciences 1998 Spring; 10(2):187-93.
    View PubMed
  83. Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, McCaffrey TV, Olsen KD. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys 1998 Feb 1; 40(3):529-34.
    View PubMed
  84. Suman VJ, Van Winter JT, Evans MP, Simmons PS, Jacobsen SJ, Manolis AL. Levonorgestrel contraceptive implants in female patients 14 to 21 years old. Mayo Clin Proc 1998 Jan; 73(1):10-6.
    View PubMed
  85. Sloan JA, O'Fallon JR, Suman VJ, Sargent DJ. Incorporating quality of life measurement in oncology clinical trials. Proceedings of the American Statistical Association 1998:282-7.
  86. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997 Dec; 21(12):1455-65.
    View PubMed
  87. Krahn LE, Reese MM, Rummans TA, Peterson GC, Suman VJ, Sharbrough FW, Cascino GD. Health care utilization of patients with psychogenic nonepileptic seizures. Psychosomatics 1997 Nov-Dec; 38(6):535-42.
    View PubMed
  88. Aust MR, Olsen KD, Lewis JE, Nascimento AG, Meland NB, Foote RL, Suman VJ. Angiosarcomas of the head and neck: clinical and pathologic characteristics. Annals of Otology, Rhinology & Laryngology 1997 Nov; 106(11):943-51.
    View PubMed
  89. Houston MS, Silverstein MD, Suman VJ. Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Community-based study. Arch Intern Med 1997 Oct 27; 157(19):2190-5.
    View PubMed
  90. Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC. Over-expression of p34(cdc2) protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc 1997 Oct; 72(10):925-929.
    View PubMed
  91. Creagan ET, Rowland KM Jr, Suman VJ, Kardinal CG, Marschke RF Jr, Marks RS, Maples WJ. Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma. Am J Clin Oncol 1997 Oct; 20(5):490-2.
    View PubMed
  92. Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF- binding proteins. Clin Cancer Res 1997 Oct; 3(10):1713-20.
    View PubMed
  93. Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma. Gynecol Oncol 1997 Aug; 66(2):238-45.
    View PubMed
  94. Schiff D, O'Neill BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 1997 Aug; 49(2):452-6.
    View PubMed
  95. Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer 1997 Jul 15; 80(2):218-24.
    View PubMed
  96. Ania BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton LJ. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc 1997 Jul; 45(7):825-31.
    View PubMed
  97. Dhodapkar M, Rubin J, Reid JM, Burch PA, Pitot HC, Buckner JC, Ames MM, Suman VJ. Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer. Clin Cancer Res 1997 Jul; 3(7):1093-100.
    View PubMed
  98. Hartmann LC, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA, Levitt R, Suman VJ, Witzig TE, Wieand HS, Miller LL, Moertel CG. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med 1997 Jun 19; 336(25):1776-80.
    View PubMed
  99. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997 Jun; 133(6):735-40.
    View PubMed
  100. Ingle JN, Kardinal CG, Suman VJ, Veeder MH, Schaefer PL, Kirschling RJ, Mailliard JA. Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer. Breast Cancer Research & Treatment 1997 May; 43(3):193-200.
    View PubMed
  101. Ingle JN, Twito DI, Suman VJ, Krook JE, Mailliard JA, Windschitl HE, Marschke RF. Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer. Am J Clin Oncol 1997 Feb;20(1):69-72.
    View PubMed
  102. Olsen KD, Lewis JE, Suman VJ. Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngology - Head & Neck Surgery 1997 Jan; 116(1):47-52.
    View PubMed
  103. Olsen KD, Meland NB, Aust MR, Lewis JE, Foote RL, Nascimento AG, Suman VJ. Angiosarcomas of the head and neck. Annals of Oncology Rhinology and Laryngology , 1997; 106(11):943-951.
    View PubMed
  104. Pollak M, Ingle J, Suman VJ, Kugler J. Adjuvant therapy of cancer VIII In: SE Salmon (ed). Proceedings of the Eighth International Conference on the Adjuvant Therapy of Cancer JB Lippincott 1997.
    View PubMed
  105. Hartmann LC, Tschetter LK, Habermann TM, Wieand HA, Ebbert LP, Mailliard JA, Levitt R, Suman V. G-CSF versus placebo for neutropenic patients. NEJM 1997; 336:1776-80.
    View PubMed
  106. Noyes WS, McCaffrey TV, Fabry DA, Robinette MS, Suman VJ. Effect of temperature elevation on rabbit cochlear function as measured by distortion-product otoacoustic emissions. Otolaryngology - Head & Neck Surgery 1996 Dec; 115(6):548-52.
    View PubMed
  107. Pisansky TM, Blute ML, Suman VJ, Bostwick DG, Earle JD, Zincke H. Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys 1996 Oct 1; 36(3):585-91.
    View PubMed
  108. Youdas JW, Garrett TR, Harmsen S, Suman VJ, Carey JR. Lumbar lordosis and pelvic inclination of asymptomatic adults. Phys Ther 1996 Oct; 76(10):1066-81.
    View PubMed
  109. Glikson M, von Feldt LK, Suman VJ, Hayes DL. Short- and long-term results with an active-fixation, bipolar, polyurethane-insulated atrial pacing lead. Pacing & Clinical Electrophysiology 1996 Oct; 19(10):1469-73.
    View PubMed
  110. Youdas JW, Bogard CL, Suman JV. Level of intrateam agreement on candidate scores in a structured interview process. J Allied Health 1996 Fall; 25(4):303-3.
    View PubMed
  111. Farnell GF, Buckner JC, Cascino TL, O'Connell MJ, Schomberg PJ, Suman V. Brain metastases from colorectal carcinoma. The long term survivors. Cancer 1996 Aug 15; 78(4):711-6.
    View PubMed
  112. Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol 1996 Aug; 62(2):192-8.
    View PubMed
  113. Miller CD, Laskowski ER, Suman VJ. Effect of corrective rearfoot orthotic devices on ground reaction forces during ambulation. Mayo Clin Proc 1996 Aug; 71(8):757-62.
    View PubMed
  114. Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol Oncol 1996 Mar; 60(3):363-72.
    View PubMed
  115. Foote RL, Grado GL, Buskirk SJ, Olsen KD, Bonner JA, Earle JD, Kasperbauer JL, McCaffrey TV, Suman VJ. Radiation therapy for glottic cancer using 6-MV photons. Cancer 1996 Jan 15; 77(2):381-6.
    View PubMed
  116. Pisansky TM, Zincke H, Suman VJ, Bostwick DG, Earle JD, Oesterling JE. Correlation of pre-therapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys 1996 Jan 1; 34(1):33-39.
    View PubMed
  117. Youdas JW, Bogard CL, Suman VJ. Level of intrateam agreement on candidate scores in a structured interview process. Journal of Allied Health 1996; 25(4):303-313.
    View PubMed
  118. Rasmussen NH, Colligan RC, Suman VJ. An investigation of clinic-based laboratory measures in the differential diagnosis of attention-deficit hyperactivity disorder (ADHD) versus externalizing disruptive behavior disorder. Archives of clinical Neuropsychology 1996; 11(5):439-440.
    View PubMed
  119. Ingle JN, Kardinal CG, Suman VJ, Krook JE, Hatfield AK. Octreotide as first-line treatment for women with metastatic breast cancer. Invest New Drugs 1996; 14(2):235-7.
    View PubMed
  120. Carey JR, Bogard CL, Youdas JW, Suman VJ. Stimulus-response compatibility effects in a manual tracking task. Percept Mot Skills 1995 Dec; 81(3 Pt 2):1155-70.
    View PubMed
  121. Lynn S, Pool A, Rose D, Brey R, Suman V. Randomized trial of the canalith repositioning procedure. Otolaryngology - Head & Neck Surgery 1995 Dec; 113(6):712-20.
    View PubMed
  122. Soundy TJ, Lucas AR, Suman VJ, Melton LJ. Bulimia nervosa in Rochester, Minnesota from 1980 to 1990. Psychol Med 1995 Sep; 25(5):1065-71.
    View PubMed
  123. Houston MS, Silverstein MD, Suman VJ. Community-acquired lower respiratory tract infection in the elderly: a community-based study of incidence and outcome. J Am Board Fam Pract 1995 Sep-Oct; 8(5):347-56.
    View PubMed
  124. Brey RH, Facer GW, Trine MB, Lynn SG, Peterson AM, Suman VJ. Vestibular effects associated with implantation of a multiple channel cochlear prosthesis. Am J Otol 1995 Jul; 16(4):424-30.
    View PubMed
  125. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995 Jul; 70(7):628-33.
    View PubMed
  126. Evans MP, Webb MJ, Gaffey TA, Katzmann JA, Suman VJ, Hu TC. DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients. Cancer 1995 May 1; 75(9):2295-8.
    View PubMed
  127. Hayes DL, Graham KJ, Irwin M, Vidaillet H, Disler G, Sweesy M, Kincaid D, Osborn MJ, Suman VJ, Neubauer SA. Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing & Clinical Electrophysiology 1995 May; 18(5 Pt 1):999-1004.
    View PubMed
  128. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O'Fallon JR, Kelly PJ, Jack CR Jr, O'Neill BP. Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg 1995 Apr; 82(4):558-66.
    View PubMed
  129. Thomson SP, Gibbons RJ, Smars PA, Suman VJ, Pierre RV, Santrach PJ, Jiang NS. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med 1995 Mar 1; 122(5):335-41.
    View PubMed
  130. Reeder GS, Bryant SC, Suman VJ, Holmes DR Jr. Intracoronary thrombus: still a risk factor for PTCA failure? Cathet Cardiovasc Diagn 1995 Mar; 34(3):191-5.
    View PubMed
  131. Crotty TB, Li CY, Edwards WD, Suman VJ. Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. Cardiovasc Pathol 1995 Jan-Mar; 4:39-42.
  132. Youdas JW, Suman VJ, Garrett TR. Reliability of measurements of lumbar spine sagittal mobility obtained with the flexible curve. J Orthop Sports Phys Ther 1995 Jan; 21(1):13-20.
    View PubMed
  133. Baron AT, Suman VJ, Nemeth E, Salisbury JL. The pericentriolar lattice of PtK2 cells exhibits temperature and calcium-modulated behavior. J Cell Sci 1994 Nov; 107(Pt 11):2993-3003.
    View PubMed
  134. Ania BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol 1994 Oct; 47(2):89-93.
    View PubMed
  135. Youdas JW, Carey JR, Garrett TR, Suman VJ. Reliability of goniometric measurements of active arm elevation in the scapular plane obtained in a clinical setting. Arch Phys Med Rehabil 1994 Oct; 75(10):1137-44.
    View PubMed
  136. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer. Head & Neck 1994 Sep-Oct; 16(5):406-12.
    View PubMed
  137. Thomas JV, Olsen KD, Neel HB 3rd, DeSanto LW, Suman VJ. Recurrences after endoscopic management of early (T1) glottic carcinoma. Laryngoscope 1994 Sep; 104(9):1099-104.
    View PubMed
  138. Glikson M, Vonfeldt LK, Suman VJ, Hayes DL. Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead. 2. The ventricular lead. Pacing Clin Electrophysiol 1994 Sep; 17:1499-1502.
    View PubMed
  139. Glikson M, Vonfeldt LK, Suman VJ, Hayes DL. Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead. 1. The atrial lead. Pacing Clin Electrophysiol 1994 Aug; 17:1399-1404.
    View PubMed
  140. Ania BJ, Suman VJ, Fairbanks VF, Melton LJ. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc 1994 Aug; 69(8):730-5.
    View PubMed
  141. Carey JR, Bogard CL, King BA, Suman VJ. Finger-movement tracking scores in healthy subjects. Perceptual & Motor Skills 1994 Aug; 79(1 Pt 2):563-76.
    View PubMed
  142. Thomas JV, Olsen KD, Neel HB 3rd, DeSanto LW, Suman VJ. Early glottic carcinoma treated with open laryngeal procedures. Archives of Otolaryngology -- Head & Neck Surgery 1994 Mar; 120(3):264-8.
    View PubMed
  143. Stormont TJ, Suman VJ, Oesterling JE. Newly diagnosed bulbar urethral strictures: etiology and outcome of various treatments. J Urol 1993 Nov; 150(5 Pt 2):1725-8.
    View PubMed
  144. Oesterling JE, Suman VJ, Zincke H, Bostwick DG. PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. Urol Clin North Am 1993 Nov; 20(4):687-93.
    View PubMed
  145. Suman VJ, Atkinson EJ, O'Fallon WM, Black DM, Melton LJ 3rd. A nomogram for predicting lifetime hip fracture risk from radius bone mineral density and age. Bone 1993 Nov-Dec; 14(6):843-6.
    View PubMed
  146. Youdas JW, Bogard CL, Suman VJ. Reliability of goniometric measurements and visual estimates of ankle joint active range of motion obtained in a clinical setting. Arch Phys Med Rehabil 1993 Oct; 74(10):1113-8.
    View PubMed
  147. Suman VJ, Tazelaar HD, Bailey K, Melton J, Longaker MT, Stern R, Finkbeiner WE. Are patients with neoplasia at an increased risk for cardiac myxomas? Hum Pathol 1993 Sep; 24(9):1008-11.
    View PubMed
  148. Foote RL, Robinow JS, Shaw EG, Kline RW, Suman VJ, Ilstrup DM, Lee RE. Low-versus high-energy photon beams in radiotherapy for lung cancer. Med Dosim 1993 Summer; 18(2):65-72.
  149. Cersosimo E, Gharib H, Suman VJ, Goellner JR. "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc 1993 Apr; 68(4):343-8.
    View PubMed
  150. Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP. Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor. J Urol 1993 Apr; 149(4):779-82.
    View PubMed
  151. Olsen KD, Thomas JV, DeSanto LW, Suman VJ. Indications and results of cordectomy for early glottic carcinoma. Otolaryngology - Head & Neck Surgery 1993 Mar; 108(3):277-82.
    View PubMed
  152. O'Brien T, Gharib H, Suman VJ, van Heerden JA. Treatment of toxic solitary thyroid nodules: surgery versus radioactive iodine. Surgery 1992 Dec; 112(6):1166-70.
    View PubMed
  153. Youdas JW, Garrett TR, Suman VJ, Bogard CL, Hallman HO, Carey JR. Normal range of motion of the cervical spine: an initial goniometric study. Phys Ther 1992 Nov; 72(11):770-80.
    View PubMed
  154. Hayes DL, Graham KJ, Irwin M, Vidaillet H, Disler G, Sweesy M, Osborn MJ, Suman VJ, Neubauer SA, Seebandt M, et al. A multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol 1992 Jul; 15(7):1033-9.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.